Plain-English translation of NCT07033572 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Thyroid Neoplasms research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new way to treat papillary thyroid cancer when it appears on both sides of the thyroid gland. Instead of removing the entire thyroid (which most patients currently undergo), this approach uses minimally invasive endoscopic surgery to remove the dominant side through a small incision under the arm, and then uses radiofrequency ablation—a heat-based technique—to treat a small nodule on the other side during the same procedure. The goal is to help patients keep some thyroid function and avoid lifelong hormone replacement therapy.
Traditional treatment for bilateral thyroid cancer requires removing the entire thyroid, which forces patients to take replacement hormones for life and carries a small risk of permanent low calcium levels. This trial exists to see whether a less invasive combination approach can control cancer effectively while preserving some of the thyroid's natural function.
You likely qualify if…
You likely don't qualify if…
You would undergo one surgical procedure under anesthesia in which surgeons remove half your thyroid through a small incision under your arm and then use heat to treat the small nodule on the other side—all in one session. After surgery, you would have follow-up visits at 1, 6, 12, 18, and 24 months, and then annually for five years, involving blood tests, ultrasound scans, and quality-of-life questionnaires to check your thyroid function, calcium levels, and overall health.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China